May 4-6, 2020 | Boston, MA

4 days, 4 streams, 7 workshops, 2 seminars, 80+ speakers

Speakers

Your Keynote Academic & Regulatory Speakers

Ariel Feldstein

Professor & Chief, Pediatric Gastroenterology

UC San Diego

Bin Gao

Chief, Laboratory of Liver Diseases

NIAAA, NIH

Frank Anania

Acting Clinical Team Leader, Division of Gastroenterology & Inborn Errors Products

FDA

Johannes Taminiau

Pediatric Committee (PDCO), European Medicines Agency (EMA), Pediatric Gastroenterologist

University Hospital Antwerp/Paola Children’s Hospital (Belgium)

Satdarshan (Paul) Singh Monga

Director

Pittsburgh Liver Research Center, University of Pittsburgh, School of Medicine

Scott Friedman

Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases

Icahn School of Medicine at Mount Sinai

Vijay Shah

Consultant, Division of Gastroenterology & Hepatology, Department of Internal Medicine

Mayo Clinic

Your Industry Speakers

Adrienne Stoudenmire

Director, Project Management, Cardiovascular/Metabolic Therapeutic Group

ICON

Ajit Dash

Safety Science Associate Medical Director

Genentech

Alka Shaunik

Senior Director – Global Medical Affairs

Sanofi

Andrew Billin

Director, Biomarker Sciences

Gilead

Ankang Li

Chief Finance Officer

Terns Pharmaceuticals

Ann-Marie Richard

Patient & External Association Engagement Lead

Pfizer

Becky Taub

Chief Medical Officer, Executive Vice President, Research & Development

Madrigal Pharmaceuticals

Bill Esler

Senior Director

Pfizer

Bob Zhang

Chief Executive Officer

Kunming Biomed International (KBI)

Bryan Fuchs

Therapeutic Area Head, GI & Liver Disease

Ferring International

Chandra Saravanan

Senior Veterinary Pathologist

Novartis Institutes for BioMedical Research (NIBR)

Claudio Mori

Medical Strategy & Portfolio Lead

Vifor Pharma

Daren Ure

Chief Scientific Officer

Hepion Pharmaceuticals

David Woodhouse

Chief Executive Officer

NGM Biopharmaceuticals

Deepa Rajagopalan

Executive Director, Strategic Planning, Enterprise Management, NASH & Primary Biliary Cholangitis

Intercept

Deepak Kumar Rajpal

Head, Bioinformatics, Translational Sciences, US

Sanofi

Derek Achila

Director & Senior Analyst – Biotechnology

Stifel Nicolaus

Eduardo Martins

Vice President, Clinical Development

Allergan

Elias Paptheodorou

Chief Executive Officer

Genkyotex

Francois Briand

Director, Research & Business Development

Physiogenex

Glenn Rosen

Vice President - Preclinical Translational Sciences & Small Molecules

Coherus Biosciences

Hank Mansbach

Chief Medical Officer

89Bio

Harold Shlevin

Chief Executive Officer & President

Galectin Therapeutics

Heather Hsu

Chief Scientific Officer

Inipharm

Hubert Chen

Chief Medical Officer

Metacrine

Jason Campagna

Chief Medical Officer

Intercept

Jay Chuang

Senior Scientist

Gilead

Jeffrey Wager

Chairman & Chief Executive Officer

Proterris

Jerry Colca

Chief Scientific Officer

Cirius Therapeutics

Joanne Imperial

Vice President, Clinical Research

Blade Therapeutics

Julia Brosnan

Senior Director, External Collaborations & Scientific Alliances

Pfizer

Kyungil Kim

Chief Operating Officer & Chief Scientific Officer

Glaceum

Liat Hayardeny

Chief Scientific Officer

Galmed Pharmaceuticals

Manu Chakravarty

Chief Medical Officer & Senior Vice President

Axcella Health

Maria Wilson

Project Team Leader

Genentech

Mark Feitelson

Chief Scientific Officer

SFA Therapeutics

Martijn Fenaux

Vice President & Head of Biology

Terns Pharmaceuticals

Melissa Palmer

Independent Consultant, (Formerly) Head of Liver Disease Development

Takeda

Michael Badman

Translational Medicine Expert

Novartis

Nikolai Naoumov

Executive Director, Hepatology Science & Innovation

Novartis

Peter Traber

Partner

Alacrita Consulting

RJ Tesi

Chief Executive Officer & Chief Medical Officer

INmune Bio

Roberto Calle

Executive Director

Pfizer

Rugmani Padmanabhan Iyer

Senior Scientist – Cardiovascular, Inflammation & Fibrosis

Merck

Rusty Montgomery

Director, Research

Miragen Therapeutics

Scott Harris

Chief Medical Officer

Altimmune

Star Seyedkazemi

Associate Vice President, Clinical Development

Allergan

Stephen Rossi

Vice President, Early Clinical Development

CymaBay Therapeutics

Tom Wynn

Vice President, Discovery Inflammation & Immunology

Pfizer

Weilin Xie

Senior Principal Scientist

Celgene

Yasmeen Rahimi

MD & Senior Research Analyst, Co-Head of Biotechnology Research

ROTH Capital Partners

Your Academic Speakers

Davide Povero

Senior Research Scientist, Department of Biochemistry & Molecular Biology

Mayo Clinic

Hannah Drescher

Postdoctoral Research Fellow

Massachusetts General Hospital

Jagpreet Chhatwal

Assistant Professor

Harvard Medical School

Jelena Mann

Professor of Epigenetics

Newcastle University

Kathleen Corey

Director, MGH Fatty Liver Clinic, MGH Gastrointestinal Unit

Massachusetts General Hospital

Laura Nagy

Professor Molecular Medicine, Staff in Pathobiology & Gastroenterology, Lerner Research Institute

Cleveland Clinic

Lee Borthwick

Fibrosis Biology Lecturer

Newcastle University

Naim Alkhouri

Director of the Metabolic Center

The Texas Liver Institute

Neil Henderson

Chair of Tissue Repair & Regeneration, Centre for Inflammation Research

University of Edinburgh

Peter Caravan

Co-Director Institute for Innovation in Imaging

Massachusetts General Hospital

Yury Popov

Assistant Professor of Medicine

Beth Israel Deaconess Medical Center

Your Patient Speakers

Anthony & Betsy Villioti

President & Co- Founders

NASH Knowledge

Donna Cryer

President & Chief Executive Officer

Global Liver Institute

Wayne Eskridge

Chief Executive Officer

Fatty Liver Foundation